Abstract:CONSPECTUS: Inflammation and other common disorders including diabetes, cardiovascular disease, and cancer are often the result of several molecular abnormalities and are not likely to be resolved by a traditional single-target drug discovery approach. Though inflammation is a normal bodily reaction, uncontrolled and misdirected inflammation can cause inflammatory diseases such as rheumatoid arthritis and asthma. Nonsteroidal anti-inflammatory drugs including aspirin, ibuprofen, naproxen, or celecoxib are commonly used to relieve aches and pains, but often these drugs have undesirable and sometimes even fatal side effects. To facilitate safer and more effective anti-inflammatory drug discovery, a balanced treatment strategy should be developed at the biological network level. In this Account, we focus on our recent progress in modeling the inflammation-related arachidonic acid (AA) metabolic network and subsequent multiple drug design. We first constructed a mathematical model of inflammation based on experimental data and then applied the model to simulate the effects of commonly used anti-inflammatory drugs. Our results indicated that the model correctly reproduced the established bleeding and cardiovascular side effects. Multitarget optimal intervention (MTOI), a Monte Carlo simulated annealing based computational scheme, was then developed to identify key targets and optimal solutions for controlling inflammation. A number of optimal multitarget strategies were discovered that were both effective and safe and had minimal associated side effects. Experimental studies were performed to evaluate these multitarget control solutions further using different combinations of inhibitors to perturb the network. Consequently, simultaneous control of cyclooxygenase-1 and -2 and leukotriene A(4) hydrolase, as well as 5-lipoxygenase and prostaglandin E-2 synthase were found to be among the best solutions. A single compound that can bind multiple targets presents advantages including low risk of drug drug interactions and robustness regarding concentration fluctuations. Thus, we developed strategies for multiple-target drug design and successfully discovered several series of multiple-target inhibitors. Optimal solutions for a disease network often involve mild but simultaneous interventions of multiple targets, which is in accord with the philosophy of traditional Chinese medicine (TCM). To this end, our AA network model can aptly explain TCM anti-inflammatory herbs and formulas at the molecular level. We also aimed to identify activators for several enzymes that appeared to have increased activity based on MTOI outcomes. Strategies were then developed to predict potential allosteric sites and to discover enzyme activators based on our hypothesis that combined treatment with the projected activators and inhibitors could balance different AA network pathways, control inflammation, and reduce associated adverse effects. Our work demonstrates that the integration of network modeling and drug discovery can provide novel solutions for disease control, which also calls for new developments in drug design concepts and methodologies. With the rapid accumulation of quantitative data and knowledge of the molecular networks of disease, we can expect an increase in the development and use of quantitative disease models to facilitate efficient and safe drug discovery.

Modeling enzyme competition in Eicosanoid metabolism in macrophage cells using a cybernetic framework

Mathematical Modeling of Eicosanoid Metabolism in Macrophage Cells: Cybernetic Framework Combined with Novel Information-Theoretic Approaches

An adaptable in silico ensemble model of the arachidonic acid cascade

Identifying important parameters in the inflammatory process with a mathematical model of immune cell influx and macrophage polarization

Pharmacodynamics Simulation of HOEC by a Computational Model of Arachidonic Acid Metabolic Network

Dynamic Simulations on the Arachidonic Acid Metabolic Network

Agent-based vs. equation-based multi-scale modeling for macrophage polarization

Large-scale computational modelling of the M1 and M2 synovial macrophages in rheumatoid arthritis

A systematic evaluation of the influence of macrophage phenotype descriptions on inflammatory dynamics

Control of Cholesterol Metabolism Using a Systems Approach

Dynamic Eicosanoid Responses Upon Different Inhibitor and Combination Treatments on the Arachidonic Acid Metabolic Network.

Cellular Phenotypic Analysis of Macrophage Activation Unveils Kinetic Responses of Agents Targeting Phosphorylation

Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model

A microfluidic coculture model for mapping signaling perturbations and precise drug screening against macrophage-mediated dynamic myocardial injury

The in silico macrophage: toward a better understanding of inflammatory disease

Logic-Based Modeling of Inflammatory Macrophage Crosstalk with Glomerular Endothelial Cells in Diabetic Kidney Disease

Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization

Effect of Aryl-Cyclohexanones and their Derivatives on Macrophage Polarization In Vitro

Diverse Ways of Perturbing the Human Arachidonic Acid Metabolic Network To Control Inflammation

Integrated cellular 4D-TIMS lipidomics and transcriptomics for characterization of anti-inflammatory and anti-atherosclerotic phenotype of MyD88-KO macrophages

Real time changes in the expression of eicosanoid synthesizing enzymes during inflammation